Valuation: Amgen Inc.

Market Cap 199B 174B 160B 149B 282B 18,855B 286B 1,921B 747B 9,305B 746B 730B 32,164B P/E 2026 *
24.1x
P/E 2027 * 22.1x
Enterprise Value 241B 211B 194B 180B 342B 22,848B 347B 2,328B 905B 11,276B 904B 884B 38,974B EV / Sales 2026 *
6.37x
EV / Sales 2027 * 6.07x
Free-Float
99.78%
Yield 2026 *
2.74%
Yield 2027 * 2.9%
1 day+0.45%
1 week+1.65%
Current month+1.65%
1 month+5.30%
3 months+8.26%
6 months+7.74%
Current year+12.46%
1 week 359.47
Extreme 359.4695
375.25
1 month 334.05
Extreme 334.0501
375.25
Current year 318.21
Extreme 318.21
391.29
1 year 269.77
Extreme 269.77
391.29
3 years 218.61
Extreme 218.61
391.29
5 years 198.64
Extreme 198.64
391.29
10 years 133.64
Extreme 133.64
391.29
Manager TitleAgeSince
Chief Executive Officer 63 01/05/2012
Director of Finance/CFO 62 13/05/2010
Director of Finance/CFO 67 01/01/2020
Director TitleAgeSince
Chairman 63 01/01/2013
Director/Board Member 65 01/01/2012
Director/Board Member 71 01/01/2012
Date Insider Type Main position Quantity % Market Cap.
05-19Free

Director

665 0.0001%
05-19Free

Director

665 0.0001%
05-19Free

Director

665 0.0001%
Change 5-day change 1-year change 3-year change Capi.($)
+0.45%+1.65%+25.65%+68.35% 199B
+2.96%+3.01%+59.87%+173.31% 1,102B
+3.05%+5.23%+72.11%+67.81% 643B
-0.04%+1.20%+35.72%+87.93% 450B
+0.87%-2.07%+27.62%+22.57% 336B
-0.69%-0.60%+28.90%+48.18% 288B
-1.12%+2.84%-26.67%-39.75% 222B
+5.21%+7.93%+21.99%+83.23% 169B
+1.48%-0.04%-4.64%-32.25% 137B
-1.39%+5.14%+13.68%+54.43% 133B
Average +0.45%+2.32%+25.42%+53.38% 367.77B
Weighted average by Cap. +1.37%+1.97%+40.81%+86.26%

Financials

2026 *2027 *
Net sales 37.78B 33.06B 30.47B 28.24B 53.61B 3,586B 54.48B 365B 142B 1,770B 142B 139B 6,117B 38.73B 33.9B 31.24B 28.95B 54.96B 3,676B 55.85B 375B 146B 1,814B 145B 142B 6,271B
Net income 8.23B 7.2B 6.64B 6.15B 11.68B 781B 11.87B 79.6B 30.96B 386B 30.9B 30.23B 1,333B 8.86B 7.76B 7.15B 6.63B 12.58B 841B 12.78B 85.73B 33.34B 415B 33.28B 32.56B 1,435B
Net Debt 42.07B 36.81B 33.93B 31.45B 59.7B 3,993B 60.66B 407B 158B 1,971B 158B 155B 6,811B 36.52B 31.95B 29.45B 27.3B 51.82B 3,466B 52.65B 353B 137B 1,710B 137B 134B 5,912B
Logo Amgen Inc.
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows: - drug sales (95.8%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.; - other 4.2%): primarily royalties. The United States account for 71.9% of net sales.
Employees
31,500
Date Price Change Volume
07/07/26 US$368.10 +0.45% 1,983,666
06/07/26 US$366.44 -2.06% 2,838,007
02/07/26 US$374.15 +3.55% 2,487,837
01/07/26 US$361.33 -0.22% 2,244,791
30/06/26 US$362.12 +0.44% 2,246,908
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
34
Last Close Price
368.10USD
Average target price
354.97USD
Spread / Average Target
-3.57%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. AMGN Stock